Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.
about
Distribution of cyclophilin B-binding sites in the subsets of human peripheral blood lymphocytesTargets for cell cycle arrest by the immunosuppressant rapamycin in yeastIdentification of a 24-kDa cytokine that is required for development of cytolytic T lymphocytes.Cardiac transplantation. Selection, immunosuppression, and survival.Counter-regulation of T cell effector function by differentially activated p38.Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin ACyclosporin A treatment converts Leishmania donovani-infected C57BL/10 (curing) mice to a noncuring phenotype.Systemic arthritis in children: a review of clinical presentation and treatmentGlucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine releaseLymphokine gene expression in vivo is inhibited by cyclosporin A.Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis.Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin AThe effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoterEvidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine.Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin AInhibition of cytokine production by cyclosporin A and transforming growth factor beta.Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice.T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.Effect of cyclosporin A on immunity to Listeria monocytogenes.In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.Characterization of a protein that regulates the DNA-binding activity of NF-AT, the nuclear factor of activated T cells.Detection of cytokine mRNA in polyclonally-, antigen- or allergen-stimulated mononuclear cells.Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene.Gamma-interferon is produced by CD3+ and CD3- lymphocytes.Corticosteroid sparing agents in asthma.Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study.Cytokine system as potential target for antipsoriatic therapy.Differential effect of cyclosporin A on activation signaling in human T cell lines.Interleukin-1 beta suppresses apoptosis in CD34 positive bone marrow cells through activation of the type I IL-1 receptor.Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages.Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells.Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.Differential inhibition by cyclosporin A reveals two pathways for activation of lymphokine synthesis in T cells.
P2860
Q24538183-C536CB08-708B-4AF4-8C71-1650E11AF907Q28277565-31086B1D-DCFE-426E-A0F4-984E1BAA5EAFQ33557907-0FC41FD0-756C-49E1-AE68-A9EA0FD194D6Q33616485-567945C1-B597-4D69-910A-FFE68BA9224EQ33702970-4A0FE822-4A57-476E-AB5C-3D07A194DD03Q34623372-792E8368-C7CD-48B2-B0DD-172056ECE316Q35105080-64DB3353-399B-4973-86F4-B9EEA8075BC7Q35659928-4002B5D9-EDFC-4D09-A237-4509DD4C50E2Q36231008-856DF140-2E42-4566-8D16-41C256DC4274Q36349639-25C95DBA-F214-49DE-A01E-B96CAC9EA634Q36350453-AA222681-9C1E-420F-87D9-94B6ABFD8363Q36351704-A4E88A2B-E724-495F-B0FC-D962947AE765Q36351738-8C35934D-8D6F-4B8C-B6C9-FBD72FF7E85DQ36354146-94BFE3F2-74DE-4D23-B0E1-49890156E95FQ36354737-8DA20326-FD95-4333-9C61-5F192C130049Q36357068-2D1A1337-0EEE-4C67-ABF6-897E481BADB4Q36357285-EA209C44-16A8-44A5-AAEF-A98423E809FFQ36860138-342E3823-C3D9-4E33-AE71-23AAF64DAD79Q36980439-12E0F2C8-A2E2-4A5A-B2F9-BAAD77C59696Q37053644-084A9C34-EF8E-44DF-8639-D1952C82F8CDQ37592267-A3DE249A-327A-4481-9631-76CC9C2C9B7BQ37649627-3D30B7FF-4EBE-4EE5-B007-394713075D7EQ37745348-8FE2D5F8-813A-4A67-8469-4231EF40B9A3Q38343022-F545B25F-C98C-4F27-9976-A18D86957F1FQ39596649-DA914B13-7C5B-4B89-A8BE-06413C61546AQ40436152-850A3A99-A81E-4B06-AABF-9296B2B1E607Q40597682-57FFE34B-7194-4D4F-98DB-05BA5B3EE697Q40689795-18951634-E81F-47DE-BCBE-67B5F1C75E73Q40922766-B19078CF-6A62-4B67-9ADD-314AF1F538FAQ41235489-29BED7A2-54F0-4EF6-B92C-3CC3F78998C8Q41975442-2A702839-9D76-42A1-A7D8-D106DA658E9CQ41997403-A6FA9E10-D7CD-4184-B399-658D7314B84FQ42930079-7E8D9A1D-70CE-4ACE-8111-C28D65530013Q46462469-142535DB-A2B5-4F5F-AA5B-DD8E3438E68A
P2860
Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Stimulation of lymphokine rele ...... d inhibition by cyclosporin A.
@ast
Stimulation of lymphokine rele ...... d inhibition by cyclosporin A.
@en
type
label
Stimulation of lymphokine rele ...... d inhibition by cyclosporin A.
@ast
Stimulation of lymphokine rele ...... d inhibition by cyclosporin A.
@en
prefLabel
Stimulation of lymphokine rele ...... d inhibition by cyclosporin A.
@ast
Stimulation of lymphokine rele ...... d inhibition by cyclosporin A.
@en
P2093
P2860
P356
P1476
Stimulation of lymphokine rele ...... d inhibition by cyclosporin A.
@en
P2093
A Granelli-Piperno
R M Steinman
P2860
P304
P356
10.1084/JEM.160.6.1792
P407
P577
1984-12-01T00:00:00Z